SUBLOCADE Rapid Initiation Extension Study

Completed · Phase 4

Conditions studied: Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate

In brief

A single center, open-label SUBLOCADE treatment extension study in which up to 25 participants diagnosed with moderate to severe opioid use disorder (OUD) could be enrolled.

Key facts

Study ID

NCT04060654

Run by

Indivior Inc.

People needed

17

Starts

2019-10-21

Expected to finish

2020-05-15

Last updated by the study team

2025-03-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed the informed consent form (ICF) and have the ability to comply with the requirements and restrictions listed therein.
• Completed the EOT Visit for the INDV-6000-403 Study.
• Is an appropriate candidate in the opinion of the Investigator or medically qualified sub-Investigator.

You may not qualify if…

• Subject compliance issues during participation in the INDV-6000-403 study which, in the opinion of the Investigator, could potentially compromise subject safety.
• Subjects who are unable, in the opinion of the Investigator or Indivior, to comply fully with the study requirements including those who are currently incarcerated or pending incarceration legal action.

Where it is running

• Hassman Research Institute — Berlin, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.